Miguel Montejo

Learn More
BACKGROUND Invasive fungal infection (IFI) following liver transplant is associated with significant morbidity and mortality. Antifungal prophylaxis is rational for liver transplant patients at high IFI risk. METHODS In this open-label, noninferiority study, patients were randomized 1:1 to receive intravenous micafungin 100 mg or center-specific standard(More)
et al. Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods. To the Editor: Rickettsia sibirica mongolitimonae has been recently reported as a subspecies of R. sibirica (1). The fi rst evidence of R. sibirica mongolitimonae pathogenicity in humans was documented in France in 1996 (2). Since then, 11(More)
Incidencia, epidemiología, factores de riesgo y pronóstico de las infecciones fúngicas en el trasplante de órgano sólido Debido a la dificultad en establecer en algunos enfermos el diagnóstico exacto, la incidencia y mortalidad asociada con las infecciones fúngicas en TOS no está bien definida. En receptores de trasplante renal, la incidencia de infección(More)
The authors have no funding and conflicts of interest to disclose. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Tropheryma whipplei endocarditis is an uncommon condition(More)
Despite advances made in the last decades, invasive fungal infections (IFI) continue to be a major cause of morbidity and mortality in solid organ transplant recipients. The most common pathogens causing IFI are Candida species, followed by Aspergillus and Cryptococcus. A shift in the epidemiology of IFI has been reported in the last few years. Non-Candida(More)
  • 1